Stem Cell Clinic

Enso Discoveries, LLC is Excited to Announce the Launch of a Human Health DivisionEnso DoctorsLed by Newly Appointed VP of Human Health, Jim Long, MT…

By Platelet Rich Plasma Injections

Jim Long, VP of Human Health Division, Enso Discoveries, LLC and head of Enso Doctors

MANHATTAN, Kan. (PRWEB) June 16, 2020

Enso Discoveries, LLC is very excited to announce the launch of Enso Doctors, a Human Division, and the hiring of Jim Long, MT (ASCP) as Vice President of Human Health. With a full R&D pipeline Enso Doctors will initially be offering the patent-pending Platelet Rich Plasma kit, Rebound PRP. The goal of these new products is to offer the latest in quality, easy to use, all inclusive kits with exceptional value and no capital required in most cases. This will allow many more physicians the ability to afford to participate with this promising regenerative therapy.

Enso Doctors utilizes the extensive experience Enso Discoveries, LLC has in regenerative medicine, led by Chief Scientific Officer, Dr. Corey Orava a regenerative medicine expert along with our consulting pathologist and excellent university relationships. We design, patent and validate all of our own unique products.

"We knew our kits would be great for physicians. Judging by the success we have seen and heard from the current group of physicians using our products we know we can add great value to those that are reluctant to invest in large PRP packages and commit capital, but want to improve their service offerings," explains CEO of Enso Discoveries, LLC, Patrick Farley.

Ive used many other kits with an average price of a PRP kit, with any volume, approaching $180-$250 each and an investment of several thousand dollars in a centrifuge, before I was asked to try the Enso Doctors Rebound PRP kit. I also only need just one of the Enso kits typically to complete my total injections, where with others I often require two or more. This is now the only kit we will use in my practice. Nowhere else can you get this type of quality, volume, shelf life and complete all inclusive sterile kit for this price. Dr. Ekwensi Griffith, DO.

As a board-certified Anesthesiologist and board-certified Pain Management physician, I am thrilled to be able to offer Enso Doctors medical grade Rebound PRP kits as an alternative to routine steroid injections or long-term pain meds, whenever possible. When my patients are given an alternative, they often choose PRP. Rebound PRP combines state-of-the-art regenerative medicine science with simplicity and affordability. Dr. Steven Peloquin, MD

Jim Long, MT (ASCP) the newly appointed Vice President assigned to launch and manage the Enso Doctors Human Health Division, comes to Enso Discoveries with years of sales and management experience in the human side. Jim started out his career as a Med-Tech working in the laboratory. After successfully doing this, he felt his personality and technical ability would be put to better use selling, where he became an award-winning leader with multiple achievements for his time with Abbott Laboratories and several other leading global medical companies.

When I was approached by Patrick Farley, the CEO of Enso Discoveries, about launching this new division and working for Enso Doctors, I was beyond impressed with the experts he had brought together for his team, and the lengths he has gone to ensure a quality, proven product is delivered. After testing Enso Doctors kits against potential competition at a major university with excellent results and then talking to current Enso PRP users, I was blown away." Jim Long, MT (ASCP) VP of Human Health, Enso Discoveries, LLC.

"If you are currently using PRP or have interest in trying Rebound PRP, Enso Doctors is offering the ability to simply try just one kit, or multiple kits, as its totally up to you. We think having to lock into an expensive package or monthly minimum, keeps many from utilizing this amazing product in their practice." Patrick Farley.

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of humans and animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the physician, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your medical products distributor about Enso Discoveries, LLC products such as Rebound PRP and Rebound PRF or learn more at http://www.ensodoctors.com.

Share article on social media or email:

Go here to see the original:
Enso Discoveries, LLC is Excited to Announce the Launch of a Human Health DivisionEnso DoctorsLed by Newly Appointed VP of Human Health, Jim Long, MT...

Worldwide Stem Cell Therapy Industry to 2027 – Growth in the Global Healthcare Market Presents Opportunities – PRNewswire

By Stell Cell Research

DUBLIN, June 18, 2020 /PRNewswire/ -- The "Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The stem cell therapy market was valued at US$ 1,534.55 million in 2019 and is estimated to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.

The increasing awareness related to the stem cells therapy in effective disease management and growing demand for regenerative medicines are the key factor driving the stem cell therapy market. However, high cost related of the stem cell therapy limits the growth of the market.

Stem cell research has been widely investigated globally for various medical applications, especially for the treatment of humans. This raises the importance of creating public awareness about stem cell research and its clinical potential. The main role of stem cells is in the replacement of dying cells and reconstruction of damaged tissues. Based on the extensive stem cell research, many scientists have claimed that these cells could probably be used in the treatment of various diseases, including cancer and cardiovascular disease.

There is a large number of potential treatment procedures that are undergoing clinical trials, and a notably few stem cell therapies have won FDA (i.e., US -Food and Drug Administration) approval for clinical usage. For instance, in 2019, the FDA approved Fedratinib for the first-line treatment for myelofibrosis. Moreover, stem cell therapies are widely used in bone marrow transplantation, and these therapies have benefited thousands of people suffering from leukemia. Hematopoietic stem cells are used for treating more than 80 medical diseases, including immune system disorders, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and several types of cancers, such as leukemia and lymphoma; this is also likely to boost the demand for this treatment procedure during the forecast period. Researchers are further investigating the use of stem cell therapies in the treatment of autoimmune disorders.

The global stem cell therapy market has been segmented on the basis of type, treatment, application type, and end user. Based on type, the market has been segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and others. The adult stem cell therapy held the largest share of the market in 2019; however, induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market during the forecast period. Based on treatment, the stem cell therapy market has been segmented into allogeneic and autologous. The allogeneic segment held a larger share of the market in 2019; however, the market for the autologous segment is expected to grow at a higher CAGR during the forecast period.

Reasons to Buy:

Key Topics Covered:

1. Introduction 1.1 Scope of the Study 1.2 Report Guidance 1.3 Market Segmentation 1.3.1 Global Stem Cell Therapy Market - By Type 1.3.2 Global Stem Cell Therapy Market - By Treatment 1.3.3 Global Stem Cell Therapy Market - By Application 1.3.4 Global Stem Cell Therapy Market - By End User 1.3.5 Global Stem Cell Therapy Market - By Geography

2. Stem Cell Therapy Market - Key Takeaways

3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research

4. Stem Cell Therapy - Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America 4.2.2 Europe 4.2.3 Asia Pacific 4.2.4 Middle East & Africa 4.2.5 South and Central America 4.3 Expert Opinion

5. Stem Cell Therapy Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management 5.1.2 Growing Demand For Regenerative Medicines 5.1.3 Growing Cancer Prevalence Across The Globe 5.2 Market Restraints 5.2.1 High Cost Related with Stem Cell Therapy 5.3 Market Opportunities 5.3.1 Growth in the Global Healthcare Market 5.4 Future Trends 5.4.1 Research Activities and Product Innovations 5.5 Impact Analysis

6. Stem Cell Therapy Market - Global Analysis 6.1 Global Stem Cell Therapy Market Revenue Forecast And Analysis 6.2 Global Stem Cell Therapy Market, By Geography - Forecast And Analysis 6.3 Market Positioning of Key Players

7. Global Stem Cell Therapy Market Analysis- by Type 7.1 Overview 7.2 Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027) 7.3 Adult Stem Cell Therapy 7.3.1 Overview 7.3.2 Adult Stem Cell Therapy : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.3 Hematopoietic Stem Cell Therapy 7.3.3.1 Overview 7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.4 Umbilical Cord Stem Cell Therapy 7.3.4.1 Overview 7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.5 Neuronal Stem Cell Therapy 7.3.5.1 Overview 7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.6 Mesenchymal Stem Cell 7.3.6.1 Overview 7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4 Induced Pluripotent Stem Cell Therapy 7.4.1 Overview 7.4.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4.3 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.5 Embryonic Stem Cell Therapy 7.5.1 Overview 7.5.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.6 Other Stem Cell Therapy 7.6.1 Overview 7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Stem Cell Therapy Market Analysis- by Treatment 8.1 Overview 8.2 Stem Cell Therapy Market, by Treatment 2019 and 2027 (%) 8.3 Allogeneic 8.3.1 Overview 8.3.2 Allogeneic: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 8.4 Autologous 8.4.1 Overview 8.4.2 Autologous: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Stem Cell Therapy Market Analysis - by Application 9.1 Overview 9.2 Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027) 9.3 Musculoskeletal 9.3.1 Overview 9.3.2 Musculoskeletal: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.4 Dermatology 9.4.1 Overview 9.4.2 Dermatology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.5 Cardiology 9.5.1 Overview 9.5.2 Cardiology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.6 Drug Discovery and Development 9.6.1 Overview 9.6.2 Drug Discovery and Development: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.7 Other Applications 9.7.1 Overview 9.7.2 Other Applications: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Stem Cell Therapy Market Analysis- by End User 10.1 Overview 10.2 Stem Cell Therapy Market, by End User 2019 and 2027 (%) 10.3 Academic & Research Institutes 10.3.1 Overview 10.3.2 Academic & Research Institutes: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.4 Hospitals & Specialty Clinics 10.4.1 Overview 10.4.2 Hospitals & Specialty Clinics : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Stem Cell Therapy Market - Geographic Analysis 11.1 North America: Stem Cell Therapy Market 11.2 Europe: Stem Cell Therapy Market 11.3 Asia Pacific: Stem Cell Therapy Market 11.4 Middle East & Africa: Stem Cell Therapy Market 11.5 South and Central America: Stem Cell Therapy Market

12. Stem Cell Therapy Market -Industry Landscape 12.1 Overview 12.2 Growth Strategies In The Stem Cell Therapy Market, 2015-2019 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview

13. COMPANY PROFILES 13.1 MEDIPOST 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Pharmicell Co., Inc. 13.3 RichSource 13.4 BioTime Inc. (Lineage Cell Therapeutics, Inc.) 13.5 Mesoblast Limited 13.6 Holostem Terapie Avanzate Srl 13.7 U.S. Stem Cell, Inc. 13.8 Caladrius Biosciences, Inc. 13.9 TiGenix NV 13.10 AlloSource

For more information about this report visit https://www.researchandmarkets.com/r/m8jwr5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the original post:
Worldwide Stem Cell Therapy Industry to 2027 - Growth in the Global Healthcare Market Presents Opportunities - PRNewswire

Stem Cell Therapy Shows Potential In Treating COVID-19 – Legal Examiner

By Stell Cell Research

As the coronavirus pandemic continues to affect millions of Americans in the U.S. alone, more than two million people have been infected and over 100,000 have died researchers are urgently seeking treatment options for COVID-19, the illness caused by the novel coronavirus. Because viruses arent treatable with antibiotics and can mutate quickly, it can be difficult for medical professionals to know the most effective course of treatment.

SARS-CoV-2, the strain of coronavirus responsible for COVID-19, has proven especially dangerous for elderly people and those with preexisting complications. About 14 percent of people over 80 who contract COVID-19 will die, and the virus hasnt shown any signs of slowing down.

While we await an effective vaccine to protect against the virus, there is a potentially promising solution: stem cell research. In May, the U.S. Food and Drug Administration approved a stem cell research trial for patients with severe cases of COVID-19. The trial includes 60 patients and uses stem cells from umbilical cord tissue.

Stem cells are a unique type of human cell that can generate new types of cells. Researchers are still discovering all of the potential benefits of stem cells, and they are sometimes used in cancer treatments like chemotherapy. Because COVID-19 currently has no definitive cure and medical professionals are still determining the best medications to treat severe cases, researchers are hopeful about the potential benefits of stem cells.

There are three main types of stem cells: embryonic, adult and pluripotent. Embryonic stem cells come from unused embryos donated after in-vitro fertilization, and they can evolve into more than one type of cell. Adult stem cells come from fully developed tissue and are typically more limited in the types of cells they can make. Pluripotent stem cells are adult stem cells that have been manipulated to be more similar to embryonic cells.

Were in the early stages of stem cell treatment for COVID-19, but there is reason to be hopeful about the promise they show. Stem cells can help control the bodys inflammatory response to a disease, and COVID-19 can cause both acute respiratory distress syndrome and pulmonary inflammation.

Right now, researchers are testing stem cell therapy with 300 patients around the U.S. All of the participants have severe cases of COVID-19 and are intubated, and about 1 in 4 coronavirus patients who are intubated will not survive. If all goes well with the clinical trial, which expects to have its results sometime in early 2021, stem cell treatment will be able to be used for even more patients and hopefully provide a way to improve the mortality rate and chances of recovery for coronavirus sufferers.

Read the original post:
Stem Cell Therapy Shows Potential In Treating COVID-19 - Legal Examiner

‘Heart-in-a-dish’ to study the effects of coronavirus – British Heart Foundation

By Stell Cell Research

18 June 2020 Lisa Jones

Category: Research

BHF-funded researchers are using stem cell heart-in-a-dish technology - originally created to explore potential treatments for heart failure - to help understand how and why coronavirus (Covid-19) impacts the heart.

Dr Sanjay Sinha and his team at University of Cambridge will use their expertise in growing 2D and 3D heart tissue in the laboratory from human stem cells, to study how the coronavirus attaches to heart muscle cells and how it affects their ability to contract and relax.

By understanding how Covid-19 may impair heart function, the team will then be able to investigate potential protective treatments.

Dr Sinha is also exploring whether the immune response from Covid-19 is responsible for damaging the heart. Molecules called cytokines are part of the immune system and when theyre in high amounts they can cause inflammation. Covid-19 has been associated with a cytokine storm which can damage cells in the body.

To investigate this immune response on the heart, the team are obtaining blood samples from people with Covid-19 at a hospital in Cambridge. The blood serum which contains the cytokines will be added onto their lab-grown 2D and 3D heart muscle cells to see if there is anything in the infected blood that has a toxic effect on the heart.

Dr Sanjay Sinha, BHF-funded researcher at the University of Cambridge, said:

Through harnessing our existing heart-in-a-dish techniques were in a prime position to investigate how and why Covid-19 can have such a devastating impact on the heart. This new understanding should provide us with a test bed for screening drugs to protect the hearts of people with Covid-19.

Professor Metin Avkiran, our Associate Medical Director, said:

Were committed to supporting the fight against Covid-19. Many of our researchers, like Dr Sinha at the BHF Centre of Research Excellence in Cambridge, are applying their expertise to understanding the harmful and potentially deadly relationship between Covid-19 and the cardiovascular system.

With increasing evidence that people with severe Covid-19 may suffer heart damage, it is vital to understand if, and how, the coronavirus attacks heart muscle as a first step to finding new treatments. Pioneering research such as this could inform how we care for people who develop Covid-19 when theyre unwell and in their long-term recovery.

Our researchers and coronavirus

Read more:
'Heart-in-a-dish' to study the effects of coronavirus - British Heart Foundation

Global Stem Cell Therapy for Osteoarthritis Market 2020: Expected Development, Share, Demand And Study Of Key Players- Research Predictions 2025 -…

By Stell Cell Research

Global Stem Cell Therapy for Osteoarthritis Market 2020 by Company, Regions, Type and Application, Forecast to 2025 aims to project the value and volume of the market and strategically profile the key players, analyze their growth strategies. The report delivers in-depth data and study of the industry dynamics of this market. The report offers an overview of global Stem Cell Therapy for Osteoarthritis market division like type, application, and region. The market report dynamics trends are made up of opportunities and challenges. The report provides a structure of the market and predicts industry share to rise within the forecast period 2025. The research thoroughly estimates the consumption volume industry by application, manufacturing technology and regions. Further, conclusion, discoveries, and future improvement openings are explored in the report.

The market report opens with an overview of the global Stem Cell Therapy for Osteoarthritis industry, which contains definitions and specifications about the industry. In the next chapter, the report explains the manufacturing cost structure, which includes a thorough analysis of the raw material suppliers and price analysis, equipment suppliers and price analysis, and analysis of labour costs and other costs. The manufacturers have been incorporated in terms of their manufacturing base, basic information, and competitors.

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Stem Cell Therapy for Osteoarthritis market.

DOWNLOAD FREE SAMPLE REPORT: https://www.researchstore.biz/sample-request/19520

Our best analysts have surveyed the market report with the reference of inventories and data given by the key players: Mesoblast, Anterogen, Regeneus, U.S. Stem Cell, Asterias Biotherapeutics

On the basis on the applications, this report focuses on the status and outlook for major applications/end users, sales volume, and growth rate for each application, including: Osteoarthritis (unspecified), Knee Osteoarthritis, Shoulder Osteoarthritis, Hip Osteoarthritis,

On the basis of types/products, this report displays the revenue (Million USD), product price, market share, and growth rate of each type, split into: Monotherapy, Combination Therapy,

Key Issues Addressed by Market:

It is very significant to have global Stem Cell Therapy for Osteoarthritis segmentation analysis to figure out the essential factors of growth and development of the market. The report provides well summarized and reliable information about every segment of growth, development, production, demand, types, application of the specific product which will assist players to focus and highlight on.

Moreover, each geographic segment of the global Stem Cell Therapy for Osteoarthritis market has been independently surveyed along with pricing, distribution and demand data for geographic market notably: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.researchstore.biz/report/global-stem-cell-therapy-for-osteoarthritis-market-19520

The Key Benefit of This Report:

Customization of the Report: This report can be customized to meet the clients requirements. Please connect with our sales team (sales@researchstore.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact Us Mark Stone Head of Business Development Phone: +1-201-465-4211 Email: sales@researchstore.biz Web: http://www.researchstore.biz

Read the rest here:
Global Stem Cell Therapy for Osteoarthritis Market 2020: Expected Development, Share, Demand And Study Of Key Players- Research Predictions 2025 -...

NIH announces new Transformative Research Award program for ALS – National Institutes of Health

By Stell Cell Research

News Release

Wednesday, June 17, 2020

New initiative encourages innovative research on devastating neurological disease.

The National Institutes of Health plans to invest $25 million over five years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS), a progressive and fatal neurological disease that weakens and eventually paralyzes voluntary muscles. Accelerating Leading-edge Science in ALS (ALS2) aims to answer critical questions about this disease.

Over the past few decades, there has been significant progress in our understanding of ALS, but we still do not have any breakthrough treatments for this terrible disease, said NIH Director Francis S. Collins, M.D., Ph.D. We hope this program will inject new ideas to the field to push us rapidly toward effective therapies.

Sometimes known as Lou Gehrigs disease, ALS is a neurodegenerative disease that affects motor neurons in the spinal cord that control voluntary muscles. For reasons that are currently unknown, the motor neurons die off, resulting in progressive muscle weakness that usually leads to respiratory failure. ALS is virtually always fatal, and many people die within three to five years of developing symptoms.

There is no cure for ALS. The U.S. Food and Drug Administration-approved drugs riluzole and edaravone can prolong life by a few months but do not improve symptoms. Ongoing clinical trials are looking at a range of therapeutic strategies including new drug candidates, devices to improve quality of life, and stem cell therapies. Genetic research has recently provided clues to understanding the disease, but it will take a focused investment in research from a range of scientific disciplines in order to capitalize on these insights.

ALS2 will be part of the NIH Common Funds High-Risk, High-Reward (HRHR) research program. The four initiatives of the HRHR program are a time-tested, powerful approach to sparking innovation. They support exceptionally creative research, which is inherently riskier, but has the potential to transform biomedical science. NIH will apply this potential to ALS2 through the HRHR programs Transformative Research Award initiative. The Transformative Research Award is particularly well-suited to interdisciplinary teams of scientists looking to combine their expertise and pursue new ideas with the potential to transform ALS research.

ALS2 will take a three-pronged approach to improve understanding of ALS:

Information on a Notice of Special Interest to accompany the Transformative Research Award funding opportunity will be posted here: https://commonfund.nih.gov/tra/grants.

This initiative is managed collaboratively by the NIH Common Fund, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute of Environmental Health Sciences, and the National Institute of General Medical Sciences.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Original post:
NIH announces new Transformative Research Award program for ALS - National Institutes of Health

Cambridge team probes COVID-19 impact on the heart – Business Weekly

By Stell Cell Research

University of Cambridge researchers are leveraging stem cell heart-in-a-dish technology to study the effects of coronavirus on the critical organ.

The technology was originally devised to explore potential treatments for heart failure. Now the British Heart Foundation is funding the team to help understand how and why COVID-19 impacts the heart.

Dr Sanjay Sinha and his team will exploit their expertise in growing 2D and 3D heart tissue in the laboratory from human stem cells to study how the coronavirus attaches to heart muscle cells and how it affects their ability to contract and relax.

By understanding how COVID-19 may impair heart function, the team will then be able to investigate potential protective treatments.

Dr Sinha is also exploring whether the immune response from COVID-19 is responsible for damaging the heart. Molecules called cytokines are part of the immune system and when theyre in high amounts they can cause inflammation. COVID-19 has been associated with a cytokine storm which can damage cells in the body.

To investigate this immune response on the heart, the team are obtaining blood samples from people with COVID-19 at a hospital in Cambridge.

The blood serum which contains the cytokines will be added onto their lab-grown 2D and 3D heart muscle cells to see if there is anything in the infected blood that has a toxic effect on the heart.

Dr Sinha said: Through harnessing our existing heart-in-a-dish techniques were in a prime position to investigate how and why COVID-19 can have such a devastating impact on the heart.

This new understanding should provide us with a test bed for screening drugs to protect the hearts of people with COVID-19.

Professor Metin Avkiran, BHFs Associate Medical Director, added: Were committed to supporting the fight against COVID-19. Many of our researchers, like Dr Sinha at the BHF Centre of Research Excellence in Cambridge, are applying their expertise to understanding the harmful and potentially deadly relationship between COVID-19 and the cardiovascular system.

With increasing evidence that people with severe COVID-19 may suffer heart damage it is vital to understand if, and how, the coronavirus attacks heart muscle as a first step to finding new treatments.

Pioneering research such as this could inform how we care for people who develop COVID-19 when theyre unwell and in their long-term recovery.

View original post here:
Cambridge team probes COVID-19 impact on the heart - Business Weekly

Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &…

By Stell Cell Research

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Stem Cell Assay market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Stem Cell Assay Market: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1632

The report begins with a brief introduction and market overview of the Stem Cell Assay industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/1632

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Stem Cell Assay

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Stem Cell Assay market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Stem Cell Assay market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Stem Cell Assay market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Stem Cell Assay market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Stem Cell Assay market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report: https://www.coherentmarketinsights.com/insight/request-discount/1632

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: Coherent Market Insights, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com Phone: US +1-206-701-6702/UK +44-020 8133 4027

See the rest here:
Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &...

Animal Stem Cell Therapy Market What Factors will drive the Animal Stem Cell Therapy Market in Upcoming Years and How it is Going to Impact on Global…

By Stell Cell Research

This report on the global Animal Stem Cell Therapy market gives a thorough study that is primarily focused on top players and their business stratagem, geographical extent, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is explicitly prepared to explore crucial fragments of the global Animal Stem Cell Therapy market. For instance, the market dynamics section in the report gives an in-depth analysis of the drivers, restraints, trends, and opportunities in the global Animal Stem Cell Therapy market. With both qualitative and quantitative analysis, we provide you with thorough and comprehensive information on the global Animal Stem Cell Therapy market. The study also entails SWOT, PESTLE, and Porters Five Forces analyses of the global Animal Stem Cell Therapy market.

This is the most recent report inclusive of the COVID-19 effects on the functioning of the market. It is well known that some changes, for the worse, were administered by the pandemic on all industries. The current scenario of the business sector and pandemics impact on the past and future of the industry are covered in this report.

Interested in this Animal Stem Cell Therapy market report? Get your FREE sample now! https://www.marketographics.com/sample-enquiry-form/4606

Global Animal Stem Cell Therapy market competition by top manufacturers/players, with Animal Stem Cell Therapy sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including:

VETSTEM BIOPHARMA MediVet Biologic J-ARM Celavet Magellan Stem Cells U.S. Stem Cell Cells Power Japan ANIMAL CELL THERAPIES Animal Care Stem Cell Therapy Sciences VetCell Therapeutics Animacel Aratana Therapeutics

The report is collated with the help of advanced tools and the recent primary and secondary research methodologies. Our expert analysts gather information and data available in the annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases. In order to ensure the authenticity of the information and data studied in this report, our researchers undertake paid primary interviews with industry experts alongside other relevant entities associated with the global Animal Stem Cell Therapy market.

By Type

Dogs Horses Others

By Application

Veterinary Hospitals Research Organizations

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketographics.com/discount-enquiry-form/4606

Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America Brazil, Argentina, Colombia and Chile etc.)

Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Objective of Studies:

If you have any special requirement, please let us know and we can provide you the report as your requirement.

#Animal Stem Cell Therapy Market Report to grow your business needs and avail 15% FREE customization on the [emailprotected] https://www.marketographics.com/request-customization-form/4606

To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing, with strategic sourcing.

Here are the questions we answer

Browse complete Animal Stem Cell Therapy report description And Full TOC @ https://www.marketographics.com/industry-reports/animal-stem-cell-therapy-market

To summarize, the global Animal Stem Cell Therapy market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:With reports from over 500 prominent publishers as well as daily updates on our collection, intended to empower companies and individuals catch-up with vital insights on industries operating across different geographies, along with the trends, share, size and growth rate of market verticals and numerous other services, we have our fingers dipped in just about everything market research-related. Besides meticulously curated research reports, our clients can also access our specialized services without any additional charges to gain vital market insights.

Contact Us: John Watson Head of Business Development Office No, 203 Chandan Nagar, Kharadi Pune, Maharashtra 411014 Direct Line:+918484002482 Visit our News Site: http://newssucceed.com

Visit link:
Animal Stem Cell Therapy Market What Factors will drive the Animal Stem Cell Therapy Market in Upcoming Years and How it is Going to Impact on Global...

What are the 3D Cell Culture Market Key Insights and COVID-19 Business Impact? – 3rd Watch News

By Stell Cell Research

Post COVID-19 Impact on 3D Cell Culture Market

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following: Long-term and short-term impact of Covid-19 on the market Cascading impact of Covid-19 on 3D Cell Culture Market, due to the impact on its extended ecosystem Understanding the market behavior Pre- and Post-COVID-19 pandemic Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity Well help you fight this crisis through our business intelligence solutions.

Connect with Analyst to Reveal How COVID-19 Impacting On 3D Cell Culture Market: https://www.researchdive.com/connect-to-analyst/73

Pre COVID-19 Analysis of 3D Cell Culture Market

According to a study of Research Dive, global 3D Cell Culture market forecast shall cross $12,638.8 million by 2026, growing at a CAGR of 29.4 during forecast period.

3D Cell culture is an essential tool in clinical analysis and biological science. It has multiple applications such as in biosensors, drug screening and others. Many improvements have been made in automated high-throughput cell culture systems. Increasing demand for regenerative medicine and economic drug discovery is expected to drive the demand for the 3D cell culture market. 3D cell cultures are primarily used to observe the abnormal behavior of cells and the cell-cell interaction. Furthermore, 3D cell culture systems play a significant role in the development of precision medicine and personalized medicine. For instance, as per study of cancer researchers (University of Michigan) newly invented 3D structure could enable physicians to test medications on model tumors grown from a patients own cells. These advances are projected to boost the growth of global cell culture market. However, more complex culture system, added expenses and threats from substitutes like 2D cell cultures are projected to limit the 3D cell culture market growth.

With new advances, 3D composite scaffolds have many versatile properties. It will be tremendously useful to develop treatments for nerve disorders and spinal cord injury (SCI) by taking help of cell transplantation methodologies and biomaterials. The most remarkable advantage of 3D cell culture is, their properties can be easily adapted by modifying the structure and composition. These key factors of 3D cell culture are projected to create enormous opportunities for the growth of 3D cell culture industry.

According to Analyst Evaluation, Microchips market shall register a revenue of $2,515.5 million by the end of 2026, growing at a CAGR of 30.1% during the forecast period; this is significantly due to new advances in 3D culture organs-on-chips. Organs-on-chips allow study of human physiology and also reveal development of novel in vitro disease models. It could provide potential replacements for animals used in toxin testing and drug development. These advancements are anticipated to grow the demand of microchips in global market, and are projected to boost the global market. Scaffold-based platforms have the largest market share and this segment will register a revenue of $3,425.1 million by the end of 2026, growing at a CAGR of 28.4%. Scaffolds can be significantly used in drug development therapeutic or specialty areas; which is anticipated to fuel the of global market growth.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/73

Based on applications, the market is segmented into Stem Cell research, drug discovery, cancer research, and regenerative medicine. 3D cell culture market size for cancer research will generate a revenue of $4,057.1 million by 2026, growing at a CAGR of 28.5% throughout the forecast period; this is majorly due to various types of cancers such as breast cancer, lung cancer and others being dominant among the population. Cancer has a pervasive prevalence across the globe, which has led to rise in demand for cancer research, which is further attributed to boost the demand for 3D cell culture market. 3D cell culture market for regenerative medicine will register a revenue of $3,690.5 million by 2026, growing at a CAGR of 30.1%. Many developed and developing countries such as Japan is focusing more on contract manufacturing tie-ups, and continues to be a lucrative place for biotech ventures to do business. Japan is the world leader in regenerative medical products; these key strategies of the government are anticipated to spur the growth of 3D cell culture market.

3D cell culture market for biotechnology & pharmaceutical companies will register a revenue of $5,184.4 million by 2026, growing at a CAGR of 28.9% during the forecast period; this is majorly due to huge developments in the laboratory, technology and operations. Furthermore, rising pressure on sales of established treatments, rapid growth of cell therapies and focus on advanced manufacturing and technologies are the factors expected to grow the market.

North America 3D Cell Culture market size will cross $4,019.1 million by 2026, increasing at a healthy CAGR of 28.1%.

Heavy investments in research & development, high healthcare expenditure, and extensively increasing number of cancer cases are considered to be one of the driving factors that are booming the growth of North American market.

3D Cell Culture market share for Asia-Pacific region is expected to rise at a CAGR of 30.7% by generating a revenue of $3,020.7 million by 2026. The market growth in the region is increasing drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. Major economies such as India, Singapore, Japan and South Korea are emphasizing more on public sector openness to partnership with established companies. For instance, leading market players such as Bayer, GlaxoSmithKline and AstraZeneca are collaborating with Singapore partners across drug discovery.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

The major 3D Cell Culture manufacturers include QGel SA, Hrel Corporation, SynVivo, Greiner Bio-One International, Advanced BioMatrix, Lonza, Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek. Players using updated technologies for their 3D Cell Culture will have good probability of having success in the rapidly blooming market. For example, Lonza has innovated the RAFT 3D Culture System that produces hepatocytes with increased stability and stronger cytochrome responses.

Contact Us:

Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) + 91 (788) 802-9103 (India) +1 (917) 444-1262 (US) Toll Free : +1 -888-961-4454 Email:[emailprotected] LinkedIn:https://www.linkedin.com/company/research-dive Twitter:https://twitter.com/ResearchDive Facebook:https://www.facebook.com/Research-Dive Blog:https://www.researchdive.com/blog Follow us on:https://covid-19-market-insights.blogspot.com

Read more:
What are the 3D Cell Culture Market Key Insights and COVID-19 Business Impact? - 3rd Watch News

→←